These are interesting findings, since other authors have shown that NFIL3 increased tumor progression of triple-negative breast cancer type by suppressing NFKB inhibitor alpha (NFKBIA) transcription [42]. Here, NFIL3 is linked to triple-negative breast carcinoma.